StockClub

TBPH

TBPHTheravance Biopharma Inc$ --
Theravance Biopharma Inc

Theravance Biopharma Inc

TBPH

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
18M USD
YoY +15.0%
Operating Income
-8M USD
YoY +42.5%
Net Income
-5M USD
YoY +63.7%
EPS
-0.1$
YoY +64.4%

Revenue

$17.7M
FY2024 Q2$28.8M
$28.8M
Q2
FY2024 Q3$45.6M
$45.6M
Q3
FY2024 Q4$64.4M
$64.4M
Q4
FY2025 Q1$15.4M
$15.4M
Q1
FY2025 Q2$41.6M
$41.6M
Q2
FY2025 Q3$61.6M
$61.6M
Q3
FY2025 Q4$107.5M
$107.5M
Q4
FY2026 Q1$17.7M
$17.7M
Q1
Actual
+$2.3M (+15.0%)

Net Income

$-4.9M
FY2024 Q2$-28.2M
$-28.2M
Q2
FY2024 Q3$-40.9M
$-40.9M
Q3
FY2024 Q4$-56.4M
$-56.4M
Q4
FY2025 Q1$-13.6M
$-13.6M
Q1
FY2025 Q2$41.3M
$41.3M
Q2
FY2025 Q3$44.9M
$44.9M
Q3
FY2025 Q4$105.9M
$105.9M
Q4
FY2026 Q1$-4.9M
$-4.9M
Q1
Actual
+$8.6M (+63.7%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$71.9M
Est:$73.9M
FY2020MISS
$71.9M
FY2021BEAT
Actual:$55.3M
Est:$53.7M
FY2021BEAT
$55.3M
FY2022MISS
Actual:$51.3M
Est:$51.6M
FY2022MISS
$51.3M
FY2023MISS
Actual:$57.4M
Est:$61.5M
FY2023MISS
$57.4M
FY2024BEAT
Actual:$64.4M
Est:$62.6M
FY2024BEAT
$64.4M
FY2025MISS
Actual:$107.5M
Est:$128.9M
FY2025MISS
$107.5M

Analyst Estimates